These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5333821)

  • 1. Critical appraisal of emulsified oil adjuvants applied to viral vaccines.
    Hilleman MR
    Prog Med Virol; 1966; 8():131-82. PubMed ID: 5333821
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of inactivated Newcastle disease viral vaccines containing different emulsion adjuvants.
    Brugh M; Stone HD; Lupton HW
    Am J Vet Res; 1983 Jan; 44(1):72-5. PubMed ID: 6824228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines.
    Aucouturier J; Dupuis L; Deville S; Ascarateil S; Ganne V
    Expert Rev Vaccines; 2002 Jun; 1(1):111-8. PubMed ID: 12908518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newcastle disease oil emulsion vaccines prepared with animal, vegetable, and synthetic oils.
    Stone HD
    Avian Dis; 1997; 41(3):591-7. PubMed ID: 9356704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental squalene adjuvant. I. Preparation and testing of its effectiveness.
    Süli J; Benísek Z; Eliás D; Svrcek S; Ondrejková A; Ondrejka R; Bajová V
    Vaccine; 2004 Sep; 22(25-26):3464-9. PubMed ID: 15308373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SEPPIC vaccine adjuvants for poultry.
    Dupuis L; Ascarateil S; Aucouturier J; Ganne V
    Ann N Y Acad Sci; 2006 Oct; 1081():202-5. PubMed ID: 17135512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of adult birds with inactivated oil adjuvant vaccines. Proceedings of a symposium: International Association of Biological Standardization. Ecole Vétérinaire de Lyon, France, June 25-27, 1981.
    Dev Biol Stand; 1982; 51():1-332. PubMed ID: 7128940
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mutagenic activity of some oil adjuvants used in vaccine preparations].
    Dominici S; Di Antonio E; Vizzani A; Vivoli P
    Boll Ist Sieroter Milan; 1980; 59(3):233-4. PubMed ID: 7459023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of oil adjuvants in therapeutic vaccines.
    Aucouturier J; Ascarateil S; Dupuis L
    Vaccine; 2006 Apr; 24 Suppl 2():S2-44-5. PubMed ID: 16823921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contribution to the study and use of oily adjuvants].
    Lombardi D
    Riv Ist Sieroter Ital; 1966; 41(4):247-51. PubMed ID: 5990411
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of oil-emulsion vaccines on the occurrence of nonspecific plate agglutination reactions for Mycoplasma gallisepticum and M. synoviae.
    Glisson JR; Dawe JF; Kleven SH
    Avian Dis; 1984; 28(2):397-405. PubMed ID: 6331364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adjuvants for human vaccines].
    Bröker M; Beyer C
    Pharm Unserer Zeit; 2008; 37(1):42-51. PubMed ID: 18081081
    [No Abstract]   [Full Text] [Related]  

  • 13. Monitoring the effects of component structure and source on formulation stability and adjuvant activity of oil-in-water emulsions.
    Fox CB; Anderson RC; Dutill TS; Goto Y; Reed SG; Vedvick TS
    Colloids Surf B Biointerfaces; 2008 Aug; 65(1):98-105. PubMed ID: 18440205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines.
    Baldridge JR; Crane RT
    Methods; 1999 Sep; 19(1):103-7. PubMed ID: 10525445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of three experimental inactivated oil-emulsion Newcastle disease vaccines.
    Stone HD; Brugh M; Beard CW
    Avian Dis; 1981; 25(4):1070-6. PubMed ID: 7337607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant formulations for experimental vaccines.
    Stewart-Tull DE
    Methods Mol Med; 2003; 87():175-94. PubMed ID: 12958456
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of action of nonionic block copolymer adjuvants.
    Hunter RL; McNicholl J; Lal AA
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S95-8. PubMed ID: 7865341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine immunopotentiators of the future.
    Schijns VE; Degen WG
    Clin Pharmacol Ther; 2007 Dec; 82(6):750-5. PubMed ID: 17914440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies for safety of adjuvant 65.
    Hilleman MR; Woodhour AF; Friedman A; Phelps AH
    Ann Allergy; 1972 Aug; 30(8):477-83. PubMed ID: 5044500
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of experimental animal and vegetable oil-emulsion vaccines for Newcastle disease and avian influenza.
    Stone HD
    Avian Dis; 1993; 37(2):399-405. PubMed ID: 8363505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.